SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC BBIO Holdings History
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC held 1.13 Mil shares of BridgeBio Pharma Inc(BBIO), totaling $39.05 Mil. This investment constitutes 1% of their stock portfolio, and SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC now holds 0.59% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2025Q1. And since then SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has made 1 purchases of BBIO, at an average price of $33.72, for a total of 1.13 Mil shares. Based on historical transaction data and BBIO's current price of $45.66, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's estimated gain on his BBIO holdings is $13.49 Mil, reflecting a 35.41% gain to date.
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC BBIO ($45.66) Holding Chart
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC BBIO ($45.66) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
